Strong Revenue and EBITDA Growth
Net revenue increased by 16% year-over-year to R$936 million, while adjusted EBITDA grew by almost 24% to R$492 million with a record margin of 52.5%.
Cash Flow and EPS Performance
Cash flow from operating activities rose by almost 10% to R$470 million, and EPS increased by 23% year-over-year, reaching R$2.79.
Significant Increase in Medical Students and Seats
The number of Undergrad Medical students grew by almost 50% compared to the first quarter of 2024, with approved medical seats increasing to 3,653 after the Funic acquisition.
Credit Rating Upgrade and ESG Recognition
Moody’s upgraded Afya’s national scale credit rating from AA+.br to AAA.br with a stable outlook, and MSCI awarded a BBB ESG rating.
Growth in Medical Practice Solution and Continuing Education Segments
Net revenue for Medical Practice Solution increased by 14%, and Continuing Education saw a 9% growth year-over-year.